tiprankstipranks
Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ:ARWR
ARWR
Arrowhead Pharmaceuticals
RESEARCH TOOLSreports
Want to see ARWR full AI Analyst Report?

Arrowhead Pharmaceuticals (ARWR) Revenue

1,680 Followers
StatisticsMarket CapRevenue

Arrowhead Pharmaceuticals Revenue

Arrowhead Pharmaceuticals had a revenue of 73.74M in the quarter ending Mar 31, 2026, with -72.07%. This bring the company's revenue in the last twelve months to 622.01M, Increased -42.99%. In the fiscal year ending Sep 30, 2025, Arrowhead Pharmaceuticals had annual revenue of 829.45M with 23258.15% growth.
Revenue (ttm)
622.01M
Revenue Growth
14.09%
P/S Ratio
13.02
Revenue/Employee
$1,361,984
Employees
609
Market Cap
$10.80B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Sep 30, 2025
829.45M825.90M+23,258.15%
Sep 30, 2024
3.55M-237.18M-98.52%
Sep 30, 2023
240.74M-2.50M-1.03%
Sep 30, 2022
243.23M104.94M+75.89%
Sep 30, 2021
138.29M50.30M+57.16%
Sep 30, 2020
87.99M-80.80M-47.87%
Sep 30, 2019
168.80M152.65M+945.67%
Sep 30, 2018
16.14M-15.27M-48.60%
Sep 30, 2017
31.41M――